Lobo Genetics is a biotechnology and health care startup based in Canada, founded in 2018. The company's slogan, "Ensuring a safer cannabis experience through genetics," encapsulates its mission to enable safer cannabis use through DNA testing. Lobo Genetics offers consumers and patients actionable insights into their personal response to cannabis based on their genetic profile. Its portable device platform provides rapid results in under an hour, making it suitable for deployment in medical clinics, dispensaries, pharmacies, and retail outlets. The last investment round, a Venture Round investment at 01 January 2020, involved Ramen Ventures and Grassfed Ventures as the investors. This financial backing underscores the growing interest and confidence from venture capital in Lobo Genetics' disruptive approach to leveraging genetics in the cannabis industry. With applications spanning recreational, medical, and clinical spaces, Lobo Genetics aims to democratize the science of cannabis genetics, bringing personalized insights to a broader audience. In summary, Lobo Genetics' pioneering technology, coupled with its recent venture capital backing, positions the company as an innovative player in the evolving landscape of cannabis-related biotechnology and healthcare.
No recent news or press coverage available for Lobo Genetics.